Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients – FINITE study

Thomas Berg, Karl‐Georg Simon, Stefan Mauss, +14

Journal of Hepatology

Finite StudyMedicineHematologyHepatitisAnticoagulant +4

Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting Antivirals

Julia Dietz, S. Süsser, Johannes Vermehren, +220

Gastroenterology

Viral HepatitisDirect-acting AntiviralsAntiviral TherapyHepatitisVirology +6

A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B

Florian van Bömmel, Kerstin Stein, R Heyne, +25

Journal of Hepatology

Multicenter Randomized-controlled TrialAutoimmune DiseaseHepatologyIde Analogue CessationViral Hepatitis +6

Non-invasive Evaluation of Activity in Inflammatory Bowel Disease by Power Doppler Sonography*

R Heyne, S Rickes, P.R. Bock, +3

Zeitschrift für Gastroenterologie

Composition of HBsAg is predictive of HBsAg loss during treatment in patients with HBeAg-positive chronic hepatitis B

Maria Pfefferkorn, T Schott, Stephan Böhm, +9

Journal of Hepatology

Hepatitis DHepatologyHbsag LossViral HepatitisImmunology +4

Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year Prospective Field Practice Study in Germany

Jörg Petersen, R Heyne, Stefan Mauss, +15

Digestive Diseases and Sciences

HepatologyViral HepatitisHepatitis BHepatitisAntiviral Therapy +6

Real‐world experience with the all‐oral, interferon‐free regimen of ombitasvir/paritaprevir/ritonavir and dasabuvir for the treatment of chronic hepatitis C virus infection in the German Hepatitis C Registry

Tania M. Welzel, Holger Hinrichsen, Christoph Sarrazin, +19

Journal of Viral Hepatitis

Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy

Julia Dietz, Velia Chiara Di Maio, Adolfo de Salazar, +76

Journal of Hepatology

Antiviral Drug DevelopmentAntiviral TherapyVirologyAntiviral DrugMedicine +1

Polymorphisms in the Toll-like receptor 3 (TLR3) gene are associated with the natural course of hepatitis B virus infection in Caucasian population

Janett Fischer, Eckart Schott, B Fülöp, +3

Scientific Reports

Baseline risk factors determine lack of biochemical response after SVR in chronic hepatitis C patients treated with DAAs

Frank Tacke, Klaus Boeker, Hartwig Klinker, +9

Liver International